{"abstract":"This is notice, in accordance with 35 U.S.C. 209 and 37 CFR 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Kite Pharma, Inc., which is located in Los Angeles, California to practice the inventions embodied in the following patent applications:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/03/25/2014-06412.html","cfr_references":[],"citation":"79 FR 16347","comment_url":null,"comments_close_on":"2014-04-24","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before April 24, 2014 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2014-06412","effective_on":null,"end_page":16348,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/03/25/2014-06412.xml","html_url":"https://www.federalregister.gov/documents/2014/03/25/2014-06412/prospective-grant-of-exclusive-license-development-of-t-cell-receptors-for-adoptive-transfer-in","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-06412?publication_date=2014-03-25","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-03-25/2014-06412/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":188,"last_updated":"2026-07-28 10:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-03-25/pdf/2014-06412.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-06412.pdf?1395665505","publication_date":"2014-03-25","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/03/25/2014-06412.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2014-04-14T06:00:21Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":16347,"subtype":null,"title":"Prospective Grant of Exclusive License: Development of T Cell Receptors for Adoptive Transfer in Humans to Treat Cancer","toc_doc":"Development of T Cell Receptors for Adoptive Transfer in Humans to Treat Cancer","toc_subject":"Exclusive Licenses:","topics":[],"type":"Notice","volume":79}